Innovative Drug Discovery and Development

Home Home Research Consortia Innovative Drug Discovery and Development

Innovative Drug Discovery and Development

Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.

New! The Cancer Therapeutics Training Program (CTTP)

The Cancer Therapeutics Training Program (CTTP) is a multi-institutional post-doctoral training program designed to prepare post-doctoral trainees for future careers in academic and/or commercial cancer therapeutics research and development (R&D). The goal of the program is to recruit and train scientists equipped with the essential skills and knowledge necessary to translate basic cancer research discoveries into commercially viable cancer therapeutics. For more information, visit the CTTP Website.

News

Pre-Application Webinar: NIA Research and Entrepreneurial Development Immersion (REDI) Program
Are you an early-career scientist, such as a graduate student, postdoc, or just starting out in academia or industry? If so, you may qualify for new training and career development opportunities through the National Institute on Aging’s (NIA) Research and Entrepreneurial Development Immersion (REDI) program. This new initiative offers early-career scientists, particularly those from diverse backgrounds, the opportunity to navigate additional professional avenues while advancing the field of age-related discoveries. Join the NIA Office of Small Business Research (OSBR) for a pre-application webinar on the REDI program on Tuesday, August 10, at 2 p.m. ET. This webinar will provide prospective applicants with an overview of the funding opportunities, including eligibility and application requirements, as well as a discussion around NIA’s critical focus areas and research priorities designed for the program.

Registration Open: Small Business Funding Opportunities from the National Cancer Institute
The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center provides funding, networking, and mentoring assistance to small businesses with early-stage innovative cancer technology projects. NCI SBIR Program Director, Dr. Xing-Jian Lou, and Program Manager, Dr. Reema Railkar, will present funding opportunities and commercialization resources for entrepreneurs and small businesses. Flyer

Registration Now Open for NCI Drug Development Workshop
How to Advance a Therapeutic Candidate from Bench to Bedside will be held as a webinar each Friday from July 23 to December 10. The goal of this workshop is to provide researchers with an interactive setting in which they will gain an understanding of product development considerations for anti-cancer therapeutics, to facilitate successful translation from preclinical to clinical studies. Flyer

Upcoming Events

There are no upcoming events at this time